John McKinney, Neeraj Dhar, François Signorino-Gelo
Recent clinical studies indicate that meropenem, a beta-lactam antibiotic, is a promising candidate for therapy of drug-resistant tuberculosis. However, meropenem is chemically unstable, requires frequent intravenous injection, and must be combined with a ...
American Society for Microbiology2015